€73 million from ESA member states towards HummingSat – SWISSto12’s next-gen affordable, compact satellite, to meet growing demand for commercial and sovereign communications

January 21, 2026|Swissto12|

Invasive treatments requiring long administration times have long been the default approaches for addressing walking and balance impairments caused by neurological disorders. Gondola, a pioneering MedTech startup, is working to change this thanks to the Gondola® medical device, which delivers the AMPS (Automated Mechanical Peripheral Stimulation) treatment, a cutting-edge approach supported by several scientific and clinical studies.

Distalmotion Raises $150 Million to Accelerate US Expansion of the DEXTER® Robotic Surgery System and Names Chas McKhann as Executive Chairman

November 18, 2025|DistalMotion|

This new funding will be used primarily to accelerate US commercial adoption of DEXTER, its soft tissue robotic surgery system, as well as to support ongoing clinical and product development initiatives. A major focus of the US expansion continues to be the Ambulatory Surgery Center (ASC) market—one of the fastest-growing segments in surgical care, driven by the ongoing shift toward efficient, outpatient surgery.

  • Adiposs Funding

Adiposs SA Secures CHF 4 Million in Series A Funding to Advance First-in-Class Contrast Agent for Brown Fat into Proof-of-Principle Clinical Development

June 30, 2025|Adiposs|

Akselos, the global leader in Structural Performance Management (SPM), has launched SPM for Flanges, a powerful new module enhancing asset integrity across industrial sites. The solution addresses a critical yet often underestimated issue: flange failures, a major source of downtime and maintenance costs.

  • Distalmotion Dexter

Distalmotion Advances US Expansion of its DEXTER® Surgical Robot with Clinical Milestones and System Enhancements

April 22, 2025|DistalMotion|

Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery, progresses on the path to expand its US footprint with the completion of cholecystectomy and benign hysterectomy clinical trials - to support 510(k) pre-market submissions for additional indications - and product enhancements to further increase procedural fluidity and wristed instrument dexterity.

  • Gondola

Startup Story #21 – Gondola

March 31, 2025|Gondola|

Invasive treatments requiring long administration times have long been the default approaches for addressing walking and balance impairments caused by neurological disorders. Gondola, a pioneering MedTech startup, is working to change this thanks to the Gondola® medical device, which delivers the AMPS (Automated Mechanical Peripheral Stimulation) treatment, a cutting-edge approach supported by several scientific and clinical studies.

  • USound

USound receives €10M minority growth investment supporting ramp-ups for next-generation audio products

August 2, 2023|U Sound GmbH|

GRAZ, AUSTRIA, August 2, 2023 — USound, the leading developer and supplier of MEMS speakers for wearable and bearable devices, has announced that it has received a €10 million growth investment supporting high-volume MEMS production ramp-ups for various true-wireless-stereo (TWS) earbud and over-the-counter (OTC) hearing aid customers.

Lydus Medical Announces $2.7M Seed round Funding Led by a strategic player and Introduces a Revolution in the Microsurgery World

May 31, 2021|Lyndus|

Lydus Medical, a portfolio company of Sanara Ventures - a JV of Teva and Philips and an anastomosis technology provider, today announced $2.7 million in a Pre-A funding, led by a leading US based strategic player with the participation of Sanara Ventures and existing shareholders.

Animatico – Interactive avatars for a contactless customer experience

July 30, 2020|Animatico|

Founded in 2019, ETH spin-​off, Animatico, has developed software for interactive, talking avatars. The animated characters can provide support in various areas of everyday life, such as buying tickets, checking into hotels, or advising on products. The systems work without any contact – certainly needed in Covid-​19 times.

INVESTIERE – “I’m bullish about the Swiss startup ecosystem”

July 9, 2020|News|

Lucian Wagner has two decades of experience as a startup investor. Together with Jacqueline Ruedin Rüsch, he runs Privilège Ventures, a seed and early-stage venture capital firm active in Switzerland and Europe. In this interview, they share the story of how they came to invest in startups and what fascinates them about the Swiss startup ecosystem.

Swiss start-ups drive research around Covid-19

May 27, 2020|Creoptix|

Swiss start-ups are very active in the quest for therapies against Covid-19. You can find several examples in our article from 5 May. According to the weekly updated view of the Covid-19 product pipeline creates by BIO’a Industry Analysis Team, Swiss companies run 25 different therapeutic programmes - more than companies from UK (22), Germany (21) or France (12).

Creoptix appoints Line Stigen Raquet as CEO

December 13, 2019|Creoptix|

Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, today announced the appointment of Line Stigen Raquet as Chief Executive Officer with effect from beginning of January 2020. After seven years in the position, Matyas Vegh has decided to pursue new opportunities outside the company.

Ready to talk?

If you wish to get in touch just go ahead.